Cost effectiveness of universal screening for hepatitis C virus infection in the era of direct-acting, pangenotypic treatment regimens | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Cost effectiveness of universal screening for hepatitis C virus infection in the era of direct-acting, pangenotypic treatment regimens

Eckman MH, Ward JW, Sherman KE. Cost effectiveness of universal screening for hepatitis C virus infection in the era of direct-acting, pangenotypic treatment regimens. Clin Gastroenterol Hepatol. 2019;17(5):930-939.e9.

Publication Type:

Journal Article

Authors:

Eckman, MH; Ward, J.W.; Sherman, K.E.

Source:

Clin Gastroenterol Hepatol, Volume 17, Issue 5, p.930-939.e9 (2019)

Cited On:

Export Citation:

RIS Format

Top